Allopurinol
Product Images NDC 33261-810

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Allopurinol (NDC 33261-810). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aidarex Pharmaceuticals Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Allopurinol Structural Formula (Allopurinol 100 mg And 300 mg For Watson 1)

FDA Label Image

Allopurinol Is A Structural Analogue Of The Natural Purine Base, Hypoxanthine. It Is An Inhibitor Of Xanthine Oxidase, The Enzyme Responsible For The Conversion Of Hypoxanthine To Xanthine And Of Xanthine To Uric Acid, The End Product Of Purine Metabolism In Man. Allopurinol Is Metabolized To The Corresponding Xanthine Analogue, Oxipurinol (alloxanthine), Which Also Is An Inhibitor Of Xanthine Oxidase. (Allopurinol 100 mg And 300 mg For Watson 2)

Allopurinol Is A Structural Analogue Of The Natural Purine Base, Hypoxanthine. It Is An Inhibitor Of Xanthine Oxidase, The Enzyme Responsible For The Conversion Of Hypoxanthine To Xanthine And Of Xanthine To Uric Acid, The End Product Of Purine Metabolism In Man. Allopurinol Is Metabolized To The Corresponding Xanthine Analogue, Oxipurinol (alloxanthine), Which Also Is An Inhibitor Of Xanthine Oxidase. (Allopurinol 100 mg And 300 mg For Watson 2)
This text appears to be a list of chemical compounds and their corresponding names. The compounds mentioned include allopurinol, oxipurinol, xanthine, uric acid, hypoxanthine, and purine-related 1H-pyrazolo compounds.*
FDA Label Image

Image Label (Allopurinol 100 mg And 300 mg For Watson 3)

Image Label (Allopurinol 100 mg And 300 mg For Watson 3)
This is a description of the medication ALLOPURINOL 100mg, manufactured by AIDAREX PHARMACEUTICALS LLC and containing 30 tablets per bottle with NDC number 33261-0810-30. The medication is in the form of a tablet and used to reduce uric acid buildup in people with gout or kidney stones. The generic name of the medication is ZYLOPRIM and it can only be dispensed with a prescription. This medication should be taken every few hours, as directed by the healthcare provider. The package insert should be read before use, and the medication should be kept out of reach of children.*
FDA Label Image

Image Label (Allopurinol 100 mg And 300 mg For Watson 4)

Image Label (Allopurinol 100 mg And 300 mg For Watson 4)
This is a description of ALOPURINOL, a drug manufactured by AIDAREX PHARMACEUTICALS LLC. The drug is available in tablet form with 300mg as the standard dose. It is the generic version of ZYLOPRIM and the active ingredient is ALLOPURINOL. The NDC code for the drug is 33261-0597-30. The recommended dosage includes taking one tablet every four hours. A batch of this drug is manufactured by WATSON PHARMA PRIVATE LTD, India.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.